πŸ‡ΊπŸ‡Έ FDA
Patent

US 10472363

SGC stimulators

granted A61KA61K31/437A61K31/4985

Quick answer

US patent 10472363 (SGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cyclerion Therapeutics, Inc.
Grant date
Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/437, A61K31/4985, A61K31/52, A61P